My husband and I participated in the Multiple Myeloma Research Foundation's Race for Research 5K Run/Walk at Carson Beach in South Boston on September 15, 2012. There were over 1,500 participants and supporters who have already raised over $300,000 for the MMRF. If you would like to contribute to my team - the Myeloma Mashers (heh) - please click here. Donations can still be made until December 31st.
It was a really fun morning – beautiful location and despite the rain, we had a great time! Luckily, the rain stopped just in time for the race to begin.
A beautiful Boston morning...until the rain started...
The clouds looked a little ominous.
We registered as walkers but ended up running…the energy of all the participants was really contagious! There are still a few races left this season if you are interested and live in the areas below. (Plus you get a free t-shirt! Who doesn't like free t-shirts?!)
October 6, 2012 --- Philadelphia, PA
November 10, 2012 --- Atlanta, GA
November 11, 2012 --- Washington, D.C.
Additional information about the MMRF and the Race for Research (taken from MMRF Race for Research Website).
The MMRF Race for Research 5K Walk/Run is an event to raise awareness and funds for research of multiple myeloma, a type of blood cancer. Held annually in nine cities across the country -- Atlanta, Boston, Chicago, Philadelphia, San Francisco, St. Louis, Tri-State (New Canaan, CT), Twin Cities, and Washington, DC -- this family friendly 5K walk/run raises both awareness and funds for multiple myeloma. Since its inception in 2001 in Chicago, the MMRF Race for Research program has raised more than $17 million to support the Multiple Myeloma Research Foundation’s urgent work. Participation offers camaraderie and knowledge sharing for patients, patient family members and friends, members of the myeloma community, and others.
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As exceptional stewards of its donors' investments, the MMRF consistently surpasses its peers in fiscal responsibility and an outstanding 90% of total budget go directly towards research and related programming.
The work of the MMRF has contributed to the FDA approval of four drugs for multiple myeloma in just four years - a track record unparalleled in oncology. These same drugs are now being explored as potential treatments for more than 30 other cancers. An outstanding 90% of the MMRF’s total budget goes directly to research and related programming. As a result, the MMRF has been awarded Charity Navigator’s coveted 4-star rating for nine consecutive years, the highest designation for outstanding fiscal responsibility and exceptional efficiency.